Skip to content
Back to Investors
Talis Capital

Talis Capital

Venture Capital

Talis Capital is a London-based venture capital firm investing in early-stage companies across the UK, Europe and the US.


Recent investments

Series A
£2.7M

FinTech Collective and Surplus Invest led the oversubscribed financing round, which brings the total Series A raise to €14m.

"Now more than ever before, we find that investors are looking to residential as a safe haven investment asset class. We have built a sourcing, renovations and property management machinery that allows us to quickly assemble €100-500m sized residential portfolios, made up of single unit assets in a matter of months, that generate very attractive stable returns almost instantly. The demand for residential is increasing, and we are confident to deploy scalable capital and generate superior-to-market returns for our investors across European markets. Our proprietary IMMO Intelligence technology helps investors target specific locations within any European city, to get their desired risk-return exposure. The success of Single-Unit-Residential (SUR) as an investment asset class in markets like the US has been very encouraging for us."
— Hans-Christian Zappel
Series A
€72.0M

The London-based real estate fintech startup secured equity and deployment capital from prominent backers to scale its property platform.

"Selling a property is the biggest and often most stressful transaction in our lives. It takes on average 191 viewings and many months to identify a buyer. About 40%2 of transactions still fall through at that point due to financing risk, changing circumstances and minds. When selling to IMMO, customers enjoy a chain-free, professional experience that is fast, reliable, transparent and convenient. We offer attractive prices without charging fees and enable homesellers to plan their lives around this important transaction."
— Hans-Christian Zappel, CEO & Founder
Series A
£5.2M

The funding round was led by signals Venture Capital with participation from Talis Capital, Mutschler Ventures, IBB Beteiligungsgesellschaft, and Cavalry Ventures.

"It will allow us to streamline high-quality care at scale and take even more work off the hospitals’ and specialists’ shoulders. Our technology helps them to operate more efficiently, be better-utilised and fully focused on what matters most: the best care for patients."
— Daniel Kolb, co-founder and MD
Seed
£2.3M

Anthemis and Menlo Ventures led the financing round alongside five new venture capital firms and angel investors.

"We are delighted to have secured the backing of a fantastic range of investors who fully understand the criticality of the service that Insurdata provides to the re/insurance market. Our work to date has exposed material deficiencies in the quality and scope of information which underwriters are reliant upon, which in turn have a detrimental effect on their ability to accurately price risk and manage portfolios effectively."
— Jason Futers, CEO